BARCLAYS PLC - UROGEN PHARMA LTD ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$48
+17.1%
3,421
-12.3%
0.00%
Q2 2023$41
-45.3%
3,901
-52.1%
0.00%
Q1 2023$75
-42.3%
8,148
-44.2%
0.00%
Q4 2022$130
-99.6%
14,599
+286.0%
0.00%
Q3 2022$31,0000.0%3,7820.0%0.00%
Q2 2022$31,000
-49.2%
3,782
-45.6%
0.00%
Q1 2022$61,000
-88.3%
6,951
-87.3%
0.00%
Q4 2021$522,000
+163.6%
54,918
+367.0%
0.00%
Q3 2021$198,000
+94.1%
11,760
+75.5%
0.00%
Q2 2021$102,000
-74.0%
6,700
-66.6%
0.00%
Q1 2021$392,000
+105.2%
20,068
+89.7%
0.00%
Q4 2020$191,000
-24.2%
10,578
-19.0%
0.00%
Q3 2020$252,000
-38.8%
13,058
-17.1%
0.00%
Q2 2020$412,000
+122.7%
15,751
+51.7%
0.00%
Q1 2020$185,000
-72.0%
10,384
-47.4%
0.00%
Q4 2019$660,000
+178.5%
19,753
+98.4%
0.00%
Q3 2019$237,000
-45.6%
9,954
-17.9%
0.00%
Q2 2019$436,000
-61.4%
12,126
-60.3%
0.00%
-100.0%
Q1 2019$1,129,000
+23.3%
30,563
+43.6%
0.00%0.0%
Q4 2018$916,000
-3.1%
21,281
+6.4%
0.00%0.0%
Q3 2018$945,000
-15.9%
20,000
-11.5%
0.00%0.0%
Q2 2018$1,124,000
-9.5%
22,600
-9.6%
0.00%0.0%
Q1 2018$1,242,00025,0000.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders